I know its a tovaxin forum, and i know its had a higher published success rate, but why is it that there are so many people excited about a phase IIb treatment (Tovaxin) over a similar treatment (in my understanding of the theorys) already in Phase 3 [(T-Cell Vaccination (aka TCV-01-002) (Sheba Medical Center)] ??
The FDA's Jenkins insists there is no official definition of Phase IIa, Phase IIb or even plain old Phase I, Phase II, and Phase III trials. He did explain that, generally speaking, early Phase II -- or Phase IIa -- studies look at the absorption, metabolism and pharmacodynamics of a drug rather than at clinical benefit or safety. The second stage of Phase II development -- so-called Phase IIb studies -- "will look more like Phase III trials" because they are looking for clear indications of clinical efficacy and safety in larger groups of patients.
Even more reason to think that the treatment will be available (in at least one country) before (and as effective) as Tovaxin.IHaveMS-com wrote:Several people at Sheba are on Opexa's scientific advisory board. Cohen, who is considered to be the father of the T-cell vaccine (he started researching it in the early 1980s), is a contributor to Opexa. They are not competing.
Hi Cure,CureOrBust wrote:Even more reason to think that the treatment will be available (in at least one country) before (and as effective) as Tovaxin.
So why are people not so excited about it? Or is it just that america has a greater penetration on english web sites?
Of course I'm biased because I'm convinced that my wife and I are better off due to your oversight. With that in mind I couldn't be happier that things worked out as they did.IHaveMS-com wrote: It was a self-inflicted wound. I think I have healed. I hope everyone else has.
Users browsing this forum: No registered users